osimertinib
astrazeneca
['nsclc', 'up next', 'lcsm,(-blcsm)', 'sclc', 'osimertinib']
tune in: coming up next #asco2023 #lcsm #egfr verdict is out: os data very positive: death rate cut 50%- for post operative #osimertinib in #nsclc 
Fellowship Program Director 👨‍🏫 Hematology & Oncology at George Washington University. Thoracic and Head&Neck cancer.